Näytä suppeat kuvailutiedot

dc.contributor.authorBöckerman, Petri
dc.contributor.authorKortelainen, Mika
dc.contributor.authorLaine, Liisa T
dc.contributor.authorNurminen, Mikko
dc.contributor.authorSaxell, Tanja
dc.date.accessioned2024-11-13T12:26:21Z
dc.date.available2024-11-13T12:26:21Z
dc.date.issued2024
dc.identifier.citationBöckerman, P., Kortelainen, M., Laine, L. T., Nurminen, M., & Saxell, T. (2024). Information Technology, Improved Access, and Use of Prescription Drugs. <i>Journal of the European Economic Association</i>, <i>Early online</i>. <a href="https://doi.org/10.1093/jeea/jvae034" target="_blank">https://doi.org/10.1093/jeea/jvae034</a>
dc.identifier.otherCONVID_213456796
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/98397
dc.description.abstractWe estimate the effects of health information technology designed to improve access to medication while limiting overuse through easier prescription renewal and improved information provision. We focus on benzodiazepines, a commonly prescribed class of mental health and insomnia medications, which are highly effective but potentially addictive. We study the staggered rollout of a nationwide electronic prescribing system over four years in Finland and use population-wide, individual-level administrative data sets. We find that e-prescribing increases average benzodiazepine use due to increased prescription renewals. The increase is most pronounced for younger patients. E-prescribing can improve the health of elderly patients and may help to balance the access-overuse trade-off. Without additional monitoring for addiction in place, it may, however, also have unintended health consequences for younger patients, who are more likely to develop mental and behavioral health disorders.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherOxford University Press (OUP)
dc.relation.ispartofseriesJournal of the European Economic Association
dc.rightsCC BY 4.0
dc.subject.otherinformation technology
dc.subject.otherelectronic prescribing
dc.subject.othermedication access
dc.subject.otheroveruse
dc.subject.otherprescription renewal
dc.titleInformation Technology, Improved Access, and Use of Prescription Drugs
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202411137240
dc.contributor.laitosKauppakorkeakoulufi
dc.contributor.laitosSchool of Business and Economicsen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1542-4766
dc.relation.volumeEarly online
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 the Authors
dc.rights.accesslevelopenAccessfi
dc.subject.ysonuoret aikuiset
dc.subject.ysoväärinkäyttö
dc.subject.ysoriippuvuus
dc.subject.ysosähköiset lääkemääräykset
dc.subject.ysopsyykenlääkkeet
dc.subject.ysosedatiivit
dc.subject.ysotietotekniikka
dc.subject.ysolääkemääräykset
dc.subject.ysoikääntyneet
dc.subject.ysobentsodiatsepiinit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p15979
jyx.subject.urihttp://www.yso.fi/onto/yso/p11535
jyx.subject.urihttp://www.yso.fi/onto/yso/p9414
jyx.subject.urihttp://www.yso.fi/onto/yso/p23927
jyx.subject.urihttp://www.yso.fi/onto/yso/p7977
jyx.subject.urihttp://www.yso.fi/onto/yso/p26814
jyx.subject.urihttp://www.yso.fi/onto/yso/p5462
jyx.subject.urihttp://www.yso.fi/onto/yso/p5840
jyx.subject.urihttp://www.yso.fi/onto/yso/p2433
jyx.subject.urihttp://www.yso.fi/onto/yso/p8433
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1093/jeea/jvae034
jyx.fundinginformationThe authors gratefully acknowledge the funding of Yrjö Jahnsson Foundation for this research (research grant No. 6701). Laine is grateful to the Yrjö Jahnsson Foundation for their funding (research grant 20166917).
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0